Cite
HARVARD Citation
Simon, J. et al. (n.d.). 28. Immunogenicity of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO™) in Participants by Age, Sex, and Baseline GP-ELISA Titer: A Post Hoc Analysis of Three Phase 2/3 Trials. Open forum infectious diseases. p. S38. [Online].